A 4/8 Subtype α-Conotoxin Vt1.27 Inhibits N-Type Calcium Channels With Potent Anti-Allodynic Effect.
Conus vitulinus
N-type calcium channels
anti-allodynic effect
electrophysiology
nicotinic acethylcholine receptor
α-conotoxin Vt1.27
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2022
2022
Historique:
received:
23
02
2022
accepted:
08
04
2022
entrez:
27
6
2022
pubmed:
28
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
A novel 4/8 subtype α-conotoxin, Vt1.27 (NCCMFHTCPIDYSRFNC-NH
Identifiants
pubmed: 35754473
doi: 10.3389/fphar.2022.881732
pii: 881732
pmc: PMC9230573
doi:
Types de publication
Journal Article
Langues
eng
Pagination
881732Informations de copyright
Copyright © 2022 Wang, Bartels, Zhao, Yousuf, Liu, Yu, Bony, Ma, Dai, Sun, Liu, Yang, Yu, Du, Adams and Dai.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Expert Rev Pharmacoecon Outcomes Res. 2006 Oct;6(5):591-601
pubmed: 20528505
Br J Pharmacol. 2013 Feb;168(4):954-65
pubmed: 22994414
Nat Protoc. 2020 May;15(5):1829-1852
pubmed: 32269383
Cell Rep. 2021 Nov 2;37(5):109931
pubmed: 34731621
Brain Res. 2005 Oct 19;1059(2):149-58
pubmed: 16182258
J Med Chem. 2018 Nov 21;61(22):10198-10205
pubmed: 30358401
Sci Rep. 2018 Sep 7;8(1):13397
pubmed: 30194442
CNS Drugs. 2013 Nov;27(11):989-1002
pubmed: 23999971
Curr Pharm Des. 2016;22(5):582-9
pubmed: 26601961
J Biol Chem. 2011 Mar 25;286(12):10233-7
pubmed: 21252227
Exp Neurol. 2016 Aug;282:37-48
pubmed: 27132993
Mol Pain. 2010 Dec 21;6:97
pubmed: 21172037
Neuropharmacology. 2012 Jun;62(7):2202-7
pubmed: 22306793
J Neurochem. 2022 Jan;160(2):154-171
pubmed: 34738241
Br J Pharmacol. 2018 Jun;175(12):2173-2184
pubmed: 28320042
Pharmacol Rev. 2018 Apr;70(2):315-347
pubmed: 29500312
J Med Chem. 2014 Dec 11;57(23):9933-44
pubmed: 25393758
Pain. 1990 Nov;43(2):205-218
pubmed: 1982347
Expert Opin Investig Drugs. 2011 Sep;20(9):1277-84
pubmed: 21740292
Pain Med. 2019 Apr 1;20(4):784-798
pubmed: 30137539
Br J Pharmacol. 2013 Sep;170(2):245-54
pubmed: 23713957
Sci Rep. 2018 Jan 17;8(1):1004
pubmed: 29343689
Physiol Rev. 2021 Jan 1;101(1):259-301
pubmed: 32584191
Pain. 2011 Feb;152(2):259-266
pubmed: 20889259
Neuroscience. 2018 Sep 1;387:135-148
pubmed: 28890048
Acta Pharm Sin B. 2021 Sep;11(9):2685-2693
pubmed: 34589389
Acta Biochim Biophys Sin (Shanghai). 2010 Sep;42(9):656-61
pubmed: 20732855
Neurosci Lett. 2018 Jul 13;679:24-34
pubmed: 29199094
J Neurochem. 2021 Oct;159(1):90-100
pubmed: 34008858
Pain. 2014 Oct;155(10):1986-95
pubmed: 25008370
Biomedicines. 2020 May 20;8(5):
pubmed: 32443665
Nature. 2021 Aug;596(7870):143-147
pubmed: 34234349
Biochim Biophys Acta. 2013 Jul;1828(7):1619-28
pubmed: 23380425
Methods Mol Biol. 2004;278:353-78
pubmed: 15318003
Mar Drugs. 2014 May 22;12(5):2970-3004
pubmed: 24857959
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11396-401
pubmed: 22745172
Chem Rev. 2014 Jun 11;114(11):5815-47
pubmed: 24720541
Chem Rev. 2019 Nov 13;119(21):11510-11549
pubmed: 31633928
Mar Drugs. 2015 May 27;13(6):3259-75
pubmed: 26023835
Br J Pharmacol. 2012 May;166(2):486-500
pubmed: 22091786
BMC Genomics. 2013 Oct 16;14:708
pubmed: 24131469
J Pain. 2012 Aug;13(8):715-24
pubmed: 22607834
Pain. 1988 Apr;33(1):87-107
pubmed: 2837713
J Neurol. 2018 Feb;265(2):231-238
pubmed: 29032407
Pharmaceuticals (Basel). 2021 Dec 18;14(12):
pubmed: 34959729
Front Pharmacol. 2020 Sep 25;11:548366
pubmed: 33101018
Biochem Pharmacol. 2021 Aug;190:114638
pubmed: 34062129